Potential role of follicle-stimulating hormone (FSH) and transforming growth factor (TGFp1) in the regulation of ovarian angiogenesis.
Expression of follicle-stimulating hormone receptor in tumor blood vessels.
The follicle-stimulating hormone receptor: A novel target in genitourinary malignancies.
Prostate--an extrapituitary source of follicle-stimulating hormone (FSH): Occurrence, localization, and de novo biosynthesis and its hormonal modulation in primates and rodents.
Hormone-refractory prostate cancer cells express functional follicle-stimulating hormone receptor (FSHR).
Genetic background of poor responders: Ovarian response to follicle-stimulating hormone (FSH) action differs considerably among women.
Recruitment of follicles by recombinant human follicle-stimulating hormone commencing in the luteal phase of the ovarian cycle.
Improved controlled ovarian hyperstimulation in poor responder in vitro fertilization patients with a microdose follicle-stimulating hormone flare, growth hormone protocol.
Minidose gonadotropin-releasing hormone agonist is the treatment of choice in poor responders with high follicle-stimulating hormone levels.